Composition:
Purified toxoids of:
Clostridium perfringens type D ≥ 200 L /mL
Clostridium septicum ≥ 100 DLM/mL
Clostridium tetani ≥ 300,000 DLM/mL
Integral anacultures of:
Clostridium chauvoei ≥ 8 µL packed cells
Inactivated bacteria of:
Pasteurella multocida multocida ≥ 1.0 x 10 8 CFU / dose
Mannheimia haemolytica ≥ 1.0 x 10 8 CFU / dose
Excipients:
Aluminum hydroxide 10% v/v
Saline solution (NaCl 0.85 % w/v) qs dose
Thimerosal 0.5 mg / dose
Indications for use:
Vaccine for the prevention of Pulpy Kidney Disease, Malignant Edema, Tetanus, Symptomatic Anthrax, Pneumonia and Septicemia.
Target species:
Bovine and ovine.
Withdrawal period:
Do not slaughter animals for human consumption before 25 days post-vaccination.
Route of administration:
Subcutaneous route.
Dosage:
Bovine:
4 mL
Ovine:
2 mL
Vaccinate and revaccinated at an interval of 28-30 days, and revaccinate with a single dose
annually.
It can be vaccinated animals from two months old.
Conservation :
2°C – 8°C. DO NOT FREEZE.
